IDO1 and colitis: Specifically, studies in mice revealed that RNase 4 modulates the intestinal microbiome by selectively limiting Parasutterella growth while promoting the indoleamine‐2,3‐dioxygenase 1 (IDO1) pathway and reducing colitis risk.